January 28, 2015
In this 2015 CAP video, Dr. Churg and Dr. Hwang talk about diagnosing and staging thymoma mesothelioma
Watch as Dr. Andrew Churg talks about diagnosing malignant mesothelioma and Dr. David Hwang talks about its staging.
Andrew Churg, MD, PhD, is a Professor of Pathology in the Department of Pathology and Laboratory Medicine at the University of British Columbia (BC) in Vancouver, BC, Canada. He is a Pathologist at Vancouver General Hospital and the author of more than 400 publications dealing with all aspects of thoracic pathology.
David Hwang, MD, PhD, FRCPC, is a Pathologist at University Health Network (UHN) and an Associate Professor in the Department of Laboratory Medicine & Pathobiology at the University of Toronto, Ontario, Canada. He completed his MD and PhD degrees at the University of Toronto, followed by residency training in Anatomical Pathology.
Watch the video for the CAP education session about thymoma mesothelioma
The Partnership, the Canadian Association of Pathologists (CAP-ACP) and Cancer Care Ontario (CCO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.